News

Exploring Amgen's Market Dynamics and Future Prospects

Exploring Amgen's Market Dynamics and Future Prospects

Insights into Amgen's Options Market Activity

Major investors, often referred to as "whales," are displaying a significantly positive outlook on Amgen. The recent activity in the options market paints an intriguing picture of investor confidence.

After examining Amgen's (NASDAQ: AMGN) options history, we've noted 10 key trades. Of these, around 40% of participants had bullish predictions, while another 40% took a bearish position.

In these trades, we identified 4 put options, which totaled $232,384, and 6 call options that amounted to $241,377. This combination of trades indicates a divide in market sentiment, showing cautious optimism among key traders.

Projected Price Target Analysis

By looking at the volume and open interest linked to these contracts, it's clear that large investors are targeting a price range between $280 and $340 for Amgen over the last three months. This suggests strategic preparation for possible fluctuations in Amgen's stock price.

Insights on Volume and Open Interest

Understanding the volume and open interest for Amgen's options can greatly enhance investment strategies. This data serves as a key indicator of liquidity and interest levels across different strike prices.

When analyzing Amgen’s trading activities in the past month, we uncover critical information about trends and patterns in the options market. Monitoring these variations helps investors gauge the overall market dynamics.

A 30-Day Overview of Call and Put Volume

Recognizing swing trading activities is essential for anticipating future stock price movements. Recent data on Amgen’s call and put options over the last month offers vital insights for investors looking to navigate these trends effectively.

Notable Options Activity

Here’s a summary of some significant options trades for AMGN:

Symbol PUT/CALL Trade Type Sentiment Expiry Date Ask Price Bid Price Trade Price Strike Price Total Trade Value Open Interest Volume
AMGN PUT SWEEP BEARISH 10/18/24 $5.30 $4.70 $4.70 $330.00 $133.90K 462 330
AMGN CALL SWEEP BULLISH 01/17/25 $24.45 $23.55 $24.35 $340.00 $61.00K 1.2K 51
AMGN CALL TRADE BEARISH 10/18/24 $60.35 $58.75 $58.75 $280.00 $41.10K 82 7
AMGN CALL SWEEP BEARISH 12/20/24 $27.45 $26.60 $26.60 $330.00 $39.90K 1.1K 1
AMGN CALL SWEEP BEARISH 12/20/24 $26.75 $26.35 $26.35 $330.00 $39.50K 1.1K 43

About Amgen

Amgen is a powerhouse in the biotechnology sector, dedicated to developing innovative human therapeutics. Its flagship products include red blood cell boosters like Epogen and Aranesp, as well as immune system enhancers Neupogen and Neulasta, along with treatments for inflammatory diseases such as Enbrel and Otezla. Amgen has also broadened its oncology offerings with significant launches like Vectibix for cancer and Prolia for osteoporosis.

Recent advancements feature therapies like Repatha for lowering cholesterol, Aimovig for treating migraines, and Lumakras for lung cancer management. The acquisition of Horizon has further bolstered Amgen's portfolio by adding treatments for rare diseases, such as Tepezza for thyroid eye disease, enhancing its already extensive biosimilar range.

Current Status of Amgen

  • The trading volume currently sits at 158,874, and AMGN’s stock price has seen a slight decrease of -0.24%, now at $336.58.
  • The Relative Strength Index (RSI) values indicate the stock may be approaching overbought conditions.
  • Investors can expect the next earnings report in 36 days, which will provide important updates on the company's performance.

While options trading can be more unpredictable than regular stock trading, it also presents opportunities for significant returns. Seasoned options traders manage this risk by staying informed daily, carefully timing their trades, and using multiple indicators to effectively read market trends.

Frequently Asked Questions

What is the recent sentiment in the options market for Amgen?

The sentiment shows mixed feelings with large investors displaying an equal balance of bullish and bearish trades.

What price targets are whales targeting for Amgen?

Whales have recently focused on a price range between $280 and $340 for Amgen's stock in the past few months.

What recent therapies has Amgen introduced?

Amgen has introduced recent therapies including Repatha for cholesterol reduction, Aimovig for migraine relief, and Lumakras for lung cancer treatment.

How does volume and open interest help traders?

Volume and open interest offer valuable insights into liquidity and investor interest, playing a crucial role in shaping trading strategies and decisions.

What should investors consider about options trading?

Options trading is known for its higher risks but also for its potential for greater rewards, making education and sound risk management crucial for investors.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Zensar’s AI Forum Puts Operations Before the AI Hype

Updated Category News Views 47

Johannesburg’s AI conversation seems to be shedding its costume jewelry at last. Zensar’s invitation-only CIS Converge 2026 forum, held on November 20, put the attention where it belongs: not on breathless demos, but on whether companies can turn AI into sturdier operations, better customer experiences, and something resembling a measurable return. That is a healthier...

Continue Reading
Lennar Lawsuit Puts Land-Light Claims Under a Microscope

Updated Category News Views 142

Three ugly selloffs, a murky land-bank story, and a fresh securities complaint have turned Lennar into the sort of holding that makes shareholders reread every footnote. The lawsuit is not a verdict, and the allegations remain unproven, but the timeline is nasty enough that investors in NYSE:LEN should not shrug it off as ordinary housing-cycle turbulence. The Dates...

Continue Reading
Anduin Opens Its Investor Portal Beyond Early Users

Updated Category News Views 30

Private-market paperwork has long been a swamp of portals, PDFs, email chains, and somebody chasing down a wire change at the worst possible moment. Anduin is taking a swing at that mess by opening its Investor Portal to all customers after building it with leading asset managers and operating it with their investors. The pitch is sensible: give limited partners one...

Continue Reading
Yangtze Documentary Frames a Decade of Economic Change

Updated Category News Views 54

A fish, a kilowatt-hour, a microchip, and a shipping container walk into the same economic story—well, not literally, thank goodness—and that is the unusual wager behind CCTV4’s upcoming Our Home, Our Yangtze. Announced in Beijing on November 19, 2026, the four-part documentary aims to recount a decade of change across the Yangtze River Economic Belt without leaning...

Continue Reading
Intel Investors Face January 12 Lead Plaintiff Deadline

Updated Category News Views 156

A Narrow Calendar Window Has Opened Intel holders have another legal deadline to put on the fridge, and this one is not a casual housekeeping item. A securities class action has been filed in the Northern District of California on behalf of investors who bought or acquired Intel shares between July 23, 2026, and October 29, 2026. The deadline to seek appointment as lead...

Continue Reading
BreakBio's New CSO Adds Vaccine Trial Credibility in Cancer

Updated Category News Views 144

Personalized cancer vaccines have no shortage of grand promises; seasoned clinical operators are the rarer commodity. That is why BreakBio's appointment of Dr. Greg Lizée as chief scientific officer deserves a closer look, even if nobody should confuse an executive hire with clinical validation. BreakBio is private, its lead program remains in development, and cancer...

Continue Reading
SAP Execution Can Steady Operations Beyond Spreadsheets

Updated Category News Views 114

Spreadsheets breed little kingdoms, and SAP is often left outside the gate. That is the operational mess Martin Rowan, managing partner at Reveal USA, Inc. in Naperville, is taking aim at in a Nov. 19, 2026 HelloNation feature. His central point is not terribly glamorous, but it is dead right: a company gets less stable when it uses SAP to explain yesterday's results...

Continue Reading
Thanksgiving AI Talk Needs Better Safety Questions

Updated Category News Views 193

Thanksgiving has somehow acquired a new household hazard: somebody casually pasting private information into a chatbot between football and dessert. SBS CyberSecurity’s point is sensible, and it lands because this is no longer a niche tech habit. Pew Research Center says 49% of U.S. adults use AI chatbots, up from roughly one-third in 2024. That kind of adoption curve...

Continue Reading
AI Shopping Answers Are Becoming Retail's New Shelf

Updated Category News Views 24

Retail’s front door is quietly being moved by a machine, and plenty of big chains appear to be staring at the old entrance. Bain’s latest work lands on an uncomfortable point: owning market share does not guarantee a retailer gets named when an AI assistant answers a shopper’s question. That ought to rattle management teams more than the usual holiday-season...

Continue Reading
Baker Tilly Breach Raises Hard Questions on Vendor Risk

Updated Category News Views 121

A Quiet Vendor Failure Can Become a Loud Problem Tax files are not ordinary customer records, and that is why this reported Baker Tilly Advisory Group breach deserves more than the usual shrug people give cyber incidents. Names and addresses are bad enough; the potential exposure of Social Security numbers and other sensitive information turns a systems failure into a...

Continue Reading

Top 5 Most Recently Viewed Articles

Massimo Group Sees Growth Amid Challenges in Q3 2024

Updated Category News Views 362

Massimo Group Reports Solid Year-to-Date Revenue Growth Massimo Group (NASDAQ: MAMO) has shared encouraging financial results for the year so far, showcasing a remarkable 20.8% increase in revenue year-over-year (YoY), totaling $91.2 million. This positive trend is largely attributed to the company's innovative production, product enhancements, and effective sales...

Continue Reading
Earnings Preview: What to Expect from Dayforce's Q2 Results

Updated Category News Views 246

Anticipation for Dayforce's Upcoming Earnings Dayforce (NYSE: DAY) is gearing up for its quarterly earnings announcement, which is scheduled for a Wednesday. Investors are eagerly awaiting insights into the company's performance, particularly focusing on earnings surpassing estimates and positive guidance for future quarters. Analyst Expectations Industry analysts predict...

Continue Reading
AutoRABIT CodeScan Enhances Security for AI-Driven Code

Updated Category News Views 71

The Essential Role of AutoRABIT CodeScan in AI Security As artificial intelligence shapes the landscape of software development, it brings both exciting innovations and significant security challenges. AutoRABIT CodeScan stands out as a crucial tool designed to address these vulnerabilities, helping developers work safely with AI-generated code. Exploring the Risks of AI...

Continue Reading
Mythos AI Breaks New Ground in Autonomous Shipping Navigation

Updated Category News Views 240

Mythos AI Achieves Milestone in Autonomous Navigation In a groundbreaking achievement, Mythos AI has successfully surpassed 11,000 miles of fully autonomous navigation, marking a significant advancement in shipping technology. The company's AI-driven navigation system not only exceeds military-grade capabilities in safety and operational efficiency but also sets a new...

Continue Reading
Explore the Rich Tapestry of Michigan's Harvest Season

Updated Category News Views 218

Experience Michigan's Harvest Season As autumn settles in, Michigan transforms into a breathtaking landscape filled with vibrant colors and rich traditions. This time of year, the state's famous agriculture thrives, creating an atmosphere that beckons travelers to experience the harvest season to the fullest. From golden fields of corn to sprawling orchards full of ripe...

Continue Reading